Qiu Weihuang, An Sheng, Wang Tingjie, Li Jiaxin, Yu Binmei, Zeng Zhenhua, Chen Zhongqing, Lin Bo, Lin Xianzhong, Gao Youguang
Department of Anesthesiology, Anesthesiology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350005, China; Guangdong Provincial Key Laboratory of Shock and Microcirculation, School of Basic Medical Sciences, Southern Medical University, Baiyun District, Guangzhou, Guangdong 510515, China.
Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Baiyun District, Guangzhou, Guangdong 510515, China; Guangdong Provincial Key Laboratory of Shock and Microcirculation, School of Basic Medical Sciences, Southern Medical University, Baiyun District, Guangzhou, Guangdong 510515, China.
Int Immunopharmacol. 2022 Nov;112:109162. doi: 10.1016/j.intimp.2022.109162. Epub 2022 Sep 5.
Ferroptosis is a regulated form of cell death. At present, the role of ferroptosis in sepsis-induced acute kidney injury (SAKI) has not been studied. Melatonin (MEL) has been reported to be an effective ferroptosis inhibitor, but it is unclear whether Melatonin can regulate ferroptosis in SAKI and whether its downstream mechanism correlates with the Nrf2/HO-1 pathway.
The cecal ligation and puncture (CLP) method and LPS injection were used to induce SAKI in mouse model. Ferroptosis markers, including malondialdehyde (MDA) and glutathione peroxidase 4 (GPX4), were assessed. The ferroptosis inhibitor ferrostatin-1 (Fer-1) was used to explore the role of ferroptosis in SAKI. The GPX4 inhibitor RSL3, the HO-1 inhibitor zinc protoporphyrin(ZnPP), and the Nrf2 inhibitor ML385 were used to explore the specific mechanism of MEL in alleviation of SAKI.
The ferroptosis level was increased in the renal tissue of CLP- and LPS-induced septic mice. Both Fer-1 and MEL administration could suppress ferroptosis and attenuate kidney injury upon sepsis challenge. RSL3 partially blocked MEL's beneficial renal-protective effects. MEL up-regulated Nrf2 and HO-1 in CLP mice, and both ZnPP and ML385 blocked the MEL-mediated effects of ferroptosis inhibition and renal protection.
Ferroptosis aggravates SAKI. Melatonin treatment suppresses ferroptosis and alleviates kidney injury in the context of experimental sepsis by upregulating Nrf2/HO-1 pathway.
铁死亡是一种受调控的细胞死亡形式。目前,铁死亡在脓毒症诱导的急性肾损伤(SAKI)中的作用尚未得到研究。据报道,褪黑素(MEL)是一种有效的铁死亡抑制剂,但尚不清楚褪黑素是否能调节SAKI中的铁死亡,以及其下游机制是否与Nrf2/HO-1途径相关。
采用盲肠结扎穿孔(CLP)法和注射脂多糖(LPS)诱导小鼠SAKI模型。评估铁死亡标志物,包括丙二醛(MDA)和谷胱甘肽过氧化物酶4(GPX4)。使用铁死亡抑制剂铁抑素-1(Fer-1)来探究铁死亡在SAKI中的作用。使用GPX4抑制剂RSL3、HO-1抑制剂锌原卟啉(ZnPP)和Nrf2抑制剂ML385来探究褪黑素减轻SAKI的具体机制。
CLP和LPS诱导的脓毒症小鼠肾组织中的铁死亡水平升高。给予Fer-1和MEL均可抑制铁死亡,并减轻脓毒症攻击后的肾损伤。RSL3部分阻断了MEL有益的肾脏保护作用。MEL上调CLP小鼠中的Nrf2和HO-1,且ZnPP和ML385均阻断了MEL介导的铁死亡抑制和肾脏保护作用。
铁死亡会加重SAKI。褪黑素治疗通过上调Nrf2/HO-1途径抑制铁死亡,并减轻实验性脓毒症背景下的肾损伤。